FOXO TECHNOLOGIES INC. Repayments of Debt
FOXO TECHNOLOGIES INC. (FOXO) reported Repayments of Debt of $500.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. repayments of debt for the quarter ending 2026-06-30 was $200.00K.
- FOXO TECHNOLOGIES INC. repayments of debt for the quarter ending 2026-03-31 was $300.00K.
- FOXO TECHNOLOGIES INC. repayments of debt for the quarter ending 2025-12-31 was $100.00K.
- FOXO TECHNOLOGIES INC. repayments of debt for the quarter ending 2024-12-31 was -$304.00K.
- FOXO TECHNOLOGIES INC. repayments of debt for fiscal 2024 was $600.00K.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month | Repayments of Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $500.00K 10-Q · filed 2026-08-14 | $600.00K derived: sum of 3 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-15 | $400.00K derived: sum of 2 quarters · filed 2026-05-15 | |||
| 2025-12-31 | $100.00K 10-K · filed 2026-04-15 | $300.00K 10-Q · filed 2026-08-14 | |||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-10 | ||||
| 2024-12-31 | -$304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $552.00K derived: sum of 2 quarters · filed 2026-04-15 | $600.00K 10-K · filed 2026-04-15 | $993.04K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $856.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $904.00K 10-Q · filed 2024-11-19 | |||
| 2024-06-30 | $48.00K 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |